1. Home
  2. MNDR vs CERO Comparison

MNDR vs CERO Comparison

Compare MNDR & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • CERO
  • Stock Information
  • Founded
  • MNDR 2016
  • CERO 2017
  • Country
  • MNDR Singapore
  • CERO United States
  • Employees
  • MNDR N/A
  • CERO N/A
  • Industry
  • MNDR
  • CERO
  • Sector
  • MNDR
  • CERO
  • Exchange
  • MNDR Nasdaq
  • CERO Nasdaq
  • Market Cap
  • MNDR 9.3M
  • CERO 8.4M
  • IPO Year
  • MNDR 2024
  • CERO N/A
  • Fundamental
  • Price
  • MNDR $2.02
  • CERO $0.96
  • Analyst Decision
  • MNDR
  • CERO
  • Analyst Count
  • MNDR 0
  • CERO 0
  • Target Price
  • MNDR N/A
  • CERO N/A
  • AVG Volume (30 Days)
  • MNDR 3.2M
  • CERO 473.6K
  • Earning Date
  • MNDR 10-29-2024
  • CERO 03-25-2025
  • Dividend Yield
  • MNDR N/A
  • CERO N/A
  • EPS Growth
  • MNDR N/A
  • CERO N/A
  • EPS
  • MNDR N/A
  • CERO N/A
  • Revenue
  • MNDR $13,968,535.00
  • CERO N/A
  • Revenue This Year
  • MNDR $188,831.77
  • CERO N/A
  • Revenue Next Year
  • MNDR $76.44
  • CERO N/A
  • P/E Ratio
  • MNDR N/A
  • CERO N/A
  • Revenue Growth
  • MNDR 77.38
  • CERO N/A
  • 52 Week Low
  • MNDR $0.23
  • CERO $0.93
  • 52 Week High
  • MNDR $29.50
  • CERO $376.00
  • Technical
  • Relative Strength Index (RSI)
  • MNDR N/A
  • CERO 26.37
  • Support Level
  • MNDR N/A
  • CERO $1.26
  • Resistance Level
  • MNDR N/A
  • CERO $1.54
  • Average True Range (ATR)
  • MNDR 0.00
  • CERO 0.15
  • MACD
  • MNDR 0.00
  • CERO 0.06
  • Stochastic Oscillator
  • MNDR 0.00
  • CERO 3.51

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Share on Social Networks: